Alterations in TLRs as new molecular markers of congenital infections with Human cytomegalovirus?

Pathogens and Disease

Volumn 70, Issue 1, 2014, Pages 3-16

  Wujcicka, Wioletta ^a   Wilczyński, Jan ^a   Nowakowska, Dorota ^a  

^a POLISH MOTHER S MEMORIAL HOSPITAL RESEARCH INSTITUTE   (Poland)

Author keywords

Alterations; Congenital cytomegaly; Human cytomegalovirus; Immunity; Pregnancy; Toll like receptors

Indexed keywords

MICRORNA; MOLECULAR MARKER; TOLL LIKE RECEPTOR; TUMOR NECROSIS FACTOR ALPHA;

CELL TYPE; CONGENITAL INFECTION; CYTOMEGALOVIRUS INFECTION; HUMAN; HUMAN CYTOMEGALOVIRUS; IMMUNE RESPONSE; IN VITRO STUDY; METHYLATION; MICROORGANISM; NONHUMAN; PREGNANT WOMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM; SYNCYTIOTROPHOBLAST; TROPHOBLAST;

ALTERATIONS; CONGENITAL CYTOMEGALY; HUMAN CYTOMEGALOVIRUS; IMMUNITY; PREGNANCY; TOLL-LIKE RECEPTORS;

ANIMALS; BIOLOGICAL MARKERS; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; FEMALE; HUMANS; PLACENTA; PREGNANCY; TOLL-LIKE RECEPTORS;

EID: 84900835914     PISSN: None     EISSN: 2049632X     Source Type: Journal    
DOI: 10.1111/2049-632X.12083     Document Type: Review

References (151)

1. Abate DA, Watanabe S & Mocarski ES (2004) Major human cytomegalovirus structural protein pp 65 (ppUL83) prevents interferon response factor 3 activation in the interferon response. J Virol 78: 10955-11006.
2. Abrahams VM, Bole-Aldo P, Kim YM, Straszewski-Chavez SL, Chaiworapongsa T, Romero R & Mor G (2004) Divergent trophoblast responses to bacterial products mediated by TLRs. J Immunol 173: 4286-4296.
3. Abrahams VM, Schaefer TM, Fahey JV, Visintin I, Wright JA, Aldo PB, Romero R, Wira CR & Mor G (2006) Expression and secretion of antiviral factors by trophoblast cells following stimulation by the TLR-3 agonist, Poly(I: C). Hum Reprod 21: 2432-2439.
4. Abrahams VM, Potter JA, Bhat G, Peltier MR, Saade G & Menon R (2013) Bacterial modulation of human fetal membrane Toll-like receptor expression. Am J Reprod Immunol 69: 33-40.
5. Ahmad-Nejad P, Hacker H, Rutz M, Bauer S, Vabulas RM & Wagner H (2002) Bacterial CpG-DNA and lipopolysaccharides activate Toll-like receptors at distinct cellular compartments. Eur J Immunol 32: 1958-1968.
6. Ahmad-Nejad P, Mrabet-Dahbi S, Breuer K, Klotz M, Werfel T, Herz U, Heeg K, Neumaier M & Renz H (2004) The toll-like receptor 2 R753Q polymorphism defines a subgroup of patients with atopic dermatitis having severe phenotype. J Allergy Clin Immunol 113: 565-567.
7. Akira S & Hemmi H (2003) Recognition of pathogen-associated molecular patterns by TLR family. Immunol Lett 85: 85-95.
8. Arav-Boger R, Wojcik GL, Duggal P, Ingersoll RG, Beaty T, Pass RF & Yolken RH (2012) Polymorphisms in Toll-like receptor genes influence antibody responses to cytomegalovirus glycoprotein B vaccine. BMC Res Notes 5: 140.
9. Atkinson C & Emery VC (2011) Cytomegalovirus quantification: where to next in optimising patient management? J Clin Virol 51: 223-228.
10. Baltimore D, Boldin MP, O'Connell RM, Rao DS & Taganov KD (2008) MicroRNAs: new regulators of immune cell development and function. Nat Immunol 9: 839-845.
11. Barreiro LB, Ben-Ali M, Quach H et al. (2009) Evolutionary dynamics of human Toll-like receptors and their different contributions to host defense. PLoS Genet 5: e1000562.
12. Beijar EC, Mallard C & Powell TL (2006) Expression and subcellular localization of TLR-4 in term and first trimester human placenta. Placenta 27: 322-326.
13. Bergstrom S (2003) Infection-related morbidities in the mother, fetus and neonate. J Nutr 133(5 suppl 2): 1656S-1660S.
14. Bochud PY, Chien JW, Marr KA et al. (2008) Toll-like receptor 4 polymorphisms and aspergillosis in stem-cell transplantation. N Engl J Med 359: 1766-1777.
15. Bodeus M & Goubau P (1999) Predictive value of maternal-IgG avidity for congenital human cytomegalovirus infection. J Clin Virol 12: 3-8.
16. Bodeus M, Feyder S & Goubau P (1998) Avidity of IgG antibodies distinguishes primary from non-primary cytomegalovirus infection in pregnant women. Clin Diagn Virol 9: 9-16.
17. Boehme KW, Guerrero M & Compton T (2006) Human cytomegalovirus envelope glycoproteins B and H are necessary for TLR2 activation in permissive cells. J Immunol 177: 7094-7102.
18. Bozza S, Bistoni F, Gaziano R et al. (2006) Pentraxin 3 protects from MCMV infection and reactivation through TLR sensing pathways leading to IRF3 activation. Blood 108: 3387-3396.
19. Brown J, Wang H, Hajishengallis GN & Martin M (2011) TLR-signaling networks: an integration of adaptor molecules, kinases, and cross-talk. J Dent Res 90: 417-427.
20. Cannon MJ (2009) Congenital cytomegalovirus (CMV) epidemiology and awareness. J Clin Virol 46(suppl 4): S6-S10.
21. Chan G & Guilbert LJ (2006) Ultraviolet-inactivated human cytomegalovirus induces placental syncytiotrophoblast apoptosis in a Toll-like receptor-2 and tumour necrosis factor-alpha dependent manner. J Pathol 210: 111-120.
22. Chang S, Dolganiuc A & Szabo G (2007) Toll-like receptors 1 and 6 are involved in TLR2-mediated macrophage activation by hepatitis C virus core and NS3 proteins. J Leukoc Biol 82: 479-487.
23. Chaturvedi A & Pierce SK (2009) How location governs toll-like receptor signaling. Traffic 10: 621-628.
24. Chaudhuri S, Lowen B, Chan G, Davey A, Riddell M & Guilbert LJ (2009) Human cytomegalovirus interacts with toll-like receptor 2 and CD14 on syncytiotrophoblasts to stimulate expression of TNFalpha mRNA and apoptosis. Placenta 30: 994-1001.
25. Chen Q, Wang H, Liu Y, Song Y, Lai L, Han Q, Cao X & Wang Q (2012) Inducible microRNA-223 down-regulation promotes TLR-triggered IL-6 and IL-1beta production in macrophages by targeting STAT3. PLoS ONE 7: e42971.
26. Choi SJ, Jung SH, Eom M, Han KH, Chung IB & Kim SK (2012) Immunohistochemical distribution of toll-like receptor 4 in preterm human fetal membrane. J Obstet Gynaecol Res 38: 108-112.
27. Cordier AG, Guitton S, Vauloup-Fellous C, Grangeot-Keros L, Benachi A & Picone O (2012) Awareness and knowledge of congenital cytomegalovirus infection among health care providers in France. J Clin Virol 55: 158-163.
28. Crane MJ, Gaddi P & Salazar-Mather TP (2012) UNC93B1 mediates innate inflammation and antiviral defense in the liver during acute murine cytomegalovirus infection. PLoS ONE 7: e39161.
29. Dalpke A & Heeg K (2002) Signal integration following Toll-like receptor triggering. Crit Rev Immunol 22: 217-250.
30. De Oliveira NF, Andia DC, Planello AC, Pasetto S, Marques MR, Nociti FH Jr, Line SR & De Souza AP (2011) TLR2 and TLR4 gene promoter methylation status during chronic periodontitis. J Clin Periodontol 38: 975-983.
31. Duan Y, Miao L, Ye H, Yang C, Fu B, Schwartz PH, Rayner S, Fortunato EA & Luo MH (2012) A faster immunofluorescence assay for tracking infection progress of human cytomegalovirus. Acta Biochim Biophys Sin (Shanghai) 44: 597-605.
32. Ducloux D, Deschamps M, Yannaraki M, Ferrand C, Bamoulid J, Saas P, Kazory A, Chalopin JM & Tiberghien P (2005) Relevance of Toll-like receptor-4 polymorphisms in renal transplantation. Kidney Int 67: 2454-2461.
33. Ducroux A, Cherid S, Benachi A, Ville Y & Leruez-Ville M (2008) Evaluation of new commercial real-time PCR quantification assay for prenatal diagnosis of cytomegalovirus congenital infection. J Clin Microbiol 46: 2078-2080.
34. Farhat K, Riekenberg S, Heine H et al. (2008) Heterodimerization of TLR2 with TLR1 or TLR6 expands the ligand spectrum but does not lead to differential signaling. J Leukoc Biol 83: 692-701.
35. Fornara C, Lilleri D, Revello MG, Furione M, Zavattoni M, Lenta E & Gerna G (2011) Kinetics of effector functions and phenotype of virus-specific and T lymphocytes in primary human cytomegalovirus infection during pregnancy. J Clin Immunol 31: 1054-1064.
36. Forster-Waldl E, Sadeghi K, Tamandl D et al. (2005) Monocyte toll-like receptor 4 expression and LPS-induced cytokine production increase during gestational aging. Pediatr Res 58: 121-124.
37. Gaj Z, Rycel M, Wilczynski J & Nowakowska D (2012) Seroprevalence of cytomegalovirus infection in the population of Polish pregnant women. Ginekol Pol 83: 337-341.
38. Genser B, Truschnig-Wilders M, Stunzner D, Landini MP & Halwachs-Baumann G (2001) Evaluation of five commercial enzyme immunoassays for the detection of human cytomegalovirus-specific IgM antibodies in the absence of a commercially available gold standard. Clin Chem Lab Med 39: 62-70.
39. Gillaux C, Mehats C, Vaiman D, Cabrol D & Breuiller-Fouche M (2011) Functional screening of TLRs in human amniotic epithelial cells. J Immunol 187: 2766-2774.
40. Gonzalez JM, Xu H, Ofori E & Elovitz MA (2007) Toll-like receptors in the uterus, cervix, and placenta: is pregnancy an immunosuppressed state? Am J Obstet Gynecol 197: 296.
41. Gou Z, Liu R, Zhao G, Zheng M, Li P, Wang H, Zhu Y, Chen J & Wen J (2012) Epigenetic modification of TLRs in leukocytes is associated with increased susceptibility to Salmonella enteritidis in chickens. PLoS ONE 7: e33627.
42. Govindaraj RG, Manavalan B, Lee G & Choi S (2010) Molecular modeling-based evaluation of hTLR10 and identification of potential ligands in Toll-like receptor signaling. PLoS ONE 5: e12713.
43. Gutierrez J & Maroto MC (1997) A comparison of two ELISA methods for the investigation of anti-cytomegalovirus IgG antibodies. Microbios 90: 151-154.
44. Halwachs-Baumann G (2007) Recent developments in human cytomegalovirus diagnosis. Expert Rev Anti Infect Ther 5: 427-439.
45. Hartel C, Finas D, Ahrens P et al. (2004) Polymorphisms of genes involved in innate immunity: association with preterm delivery. Mol Hum Reprod 10: 911-915.
46. Harwani SC, Lurain NS, Zariffard MR & Spear GT (2007) Differential inhibition of human cytomegalovirus (HCMV) by toll-like receptor ligands mediated by interferon-beta in human foreskin fibroblasts and cervical tissue. Virol J 4: 133.
47. + CTL. J Exp Med 202: 1109-1119.
48. Hengel H, Esslinger C, Pool J, Goulmy E & Koszinowski UH (1995) Cytokines restore MHC class I complex formation and control antigen presentation in human cytomegalovirus-infected cells. J Gen Virol 76: 2987-2997.
49. Holmlund U, Cebers G, Dahlfors AR, Sandstedt B, Bremme K, Ekstrom ES & Scheynius A (2002) Expression and regulation of the pattern recognition receptors Toll-like receptor-2 and Toll-like receptor-4 in the human placenta. Immunology 107: 145-151.
50. Hopkins JI, Fiander AN, Evans AS, Delchambre M, Gheysen D & Borysiewicz LK (1996) Cytotoxic T cell immunity to human cytomegalovirus glycoprotein B. J Med Virol 49: 124-131.
51. Ilievski V & Hirsch E (2010) Synergy between viral and bacterial toll-like receptors leads to amplification of inflammatory responses and preterm labor in the mouse. Biol Reprod 83: 767-773.
52. Ilievski V, Lu SJ & Hirsch E (2007) Activation of toll-like receptors 2 or 3 and preterm delivery in the mouse. Reprod Sci 14: 315-320.
53. Iversen AC, Steinkjer B, Nilsen N, Bohnhorst J, Moen SH, Vik R, Stephens P, Thomas DW, Benedict CA & Espevik T (2009) A proviral role for CpG in cytomegalovirus infection. J Immunol 182: 5672-5681.
54. Iwasaki A & Medzhitov R (2004) Toll-like receptor control of the adaptive immune responses. Nat Immunol 5: 987-995.
55. Janeway CA & Medzhitov R (2002) Innate immune recognition. Annu Rev Immunol 20: 197-216.
56. Juckem LK, Boehme KW, Feire AL & Compton T (2008) Differential initiation of innate immune responses induced by human cytomegalovirus entry into fibroblast cells. J Immunol 180: 4965-4977.
57. Kessler T, Reich M, Jahn G, Tolosa E, Beck A, Kalbacher H, Overkleeft H, Schempp S & Driessen C (2008) Human cytomegalovirus infection interferes with major histocompatibility complex type II maturation and endocytic proteases in dendritic cells at multiple levels. J Gen Virol 89: 2427-2436.
58. Khansarinejad B, Soleimanjahi H, Mirab SS, Hamidieh AA, Paryan M & Sanahmadi Y (2012) Quantitation of human cytomegalovirus DNA in plasma using an affordable in-house qPCR assay. J Virol Methods 183: 170-175.
59. Kijpittayarit S, Eid AJ, Brown RA, Paya CV & Razonable RR (2007) Relationship between Toll-like receptor 2 polymorphism and cytomegalovirus disease after liver transplantation. Clin Infect Dis 44: 1315-1320.
60. Kim YM, Romero R, Chaiworapongsa T et al. (2004) Toll-like receptor-2 and -4 in the chorioamniotic membranes in spontaneous labor at term and in preterm parturition that are associated with chorioamnionitis. Am J Obstet Gynecol 191: 1346-1355.
61. Klaffenbach D, Rascher W, Rollinghoff M, Dotsch J, Meissner U & Schnare M (2005) Regulation and signal transduction of toll-like receptors in human chorioncarcinoma cell lines. Am J Reprod Immunol 53: 77-84.
62. Klaffenbach D, Friedrich D, Strick R et al. (2011) Contribution of different placental cells to the expression and stimulation of antimicrobial proteins (AMPs). Placenta 32: 830-837.
63. Koga K & Mor G (2008) Expression and function of toll-like receptors at the maternal-fetal interface. Reprod Sci 15: 231-242.
64. Koga K & Mor G (2010) Toll-like receptors at the maternal-fetal interface in normal pregnancy and pregnancy disorders. Am J Reprod Immunol 63: 587-600.
65. Kormann MS, Ferstl R, Depner M, Klopp N, Spiller S, Illig T, Vogelberg C, von Mutius E, Kirschning CJ & Kabesch M (2009) Rare TLR2 mutations reduce TLR2 receptor function and can increase atopy risk. Allergy 64: 636-642.
66. Kouri V, Correa CB, Verdasquera D et al. (2010) Diagnosis and screening for cytomegalovirus infection in pregnant women in Cuba as prognostic markers of congenital infection in newborns: 2007-2008. Pediatr Infect Dis J 29: 1105-1110.
67. Krediet TG, Wiertsema SP, Vossers MJ, Hoeks SB, Fleer A, Ruven HJ & Rijkers GT (2007) Toll-like receptor 2 polymorphism is associated with preterm birth. Pediatr Res 62: 474-476.
68. Kruger B, Banas MC, Walberer A, Boger CA, Farkas S, Hoffmann U, Fischereder M, Banas B & Kramer BK (2010) A comprehensive genotype-phenotype interaction of different Toll-like receptor variations in a renal transplant cohort. Clin Sci (Lond) 119: 535-544.
69. Kumar H, Kawai T & Akira S (2009) Pathogen recognition in the innate immune response. Biochem J 420: 1-16.
70. Kumar H, Kawai T & Akira S (2011) Pathogen recognition by the innate immune system. Int Rev Immunol 30: 16-34.
71. Landini MP, Lazzarotto T & La PM (1984) The immune response to human cytomegalovirus-induced early nuclear and early membrane antigens and its possible clinical significance. J Infect 9: 257-263.
72. Lazarus R, Klimecki WT, Raby BA, Vercelli D, Palmer LJ, Kwiatkowski DJ, Silverman EK, Martinez F & Weiss ST (2003) Single-nucleotide polymorphisms in the Toll-like receptor 9 gene (TLR9): frequencies, pairwise linkage disequilibrium, and haplotypes in three U.S. ethnic groups and exploratory case-control disease association studies. Genomics 81: 85-91.
73. + T cells and Treg cells in HBV-related liver cirrhosis. Viral Immunol 22: 301-308.
74. Lilleri D, Fornara C, Furione M, Zavattoni M, Revello MG & Gerna G (2007) Development of human cytomegalovirus-specific T cell immunity during primary infection of pregnant women and its correlation with virus transmission to the fetus. J Infect Dis 195: 1062-1070.
75. + T cell responses in primary infection of the immunocompetent and the immunocompromised host. Clin Immunol 131: 395-403.
76. Liu J, Radler D, Illi S, Klucker E, Turan E, von Mutius E, Kabesch M & Schaub B (2011) TLR2 polymorphisms influence neonatal regulatory T cells depending on maternal atopy. Allergy 66: 1020-1029.
77. Lorenz E, Hallman M, Marttila R, Haataja R & Schwartz DA (2002) Association between the Asp299Gly polymorphisms in the Toll-like receptor 4 and premature births in the Finnish population. Pediatr Res 52: 373-376.
78. Lukaszewski T, Barlik M, Seremak-Mrozikiewicz A, Kurzawinska G, Mrozikiewicz PM, Sieroszewski P & Drews K (2009) Polymorphism in the genes of Toll-like receptors type 2 and type 4 (TLR-2 and TLR-4) and the risk of premature rupture of the membranes - preliminary study. Ginekol Pol 80: 914-919.
79. Ma Y, Krikun G, Abrahams VM, Mor G & Guller S (2007) Cell type-specific expression and function of toll-like receptors 2 and 4 in human placenta: implications in fetal infection. Placenta 28: 1024-1031.
80. Medzhitov R (2007) Recognition of microorganisms and activation of the immune response. Nature 449: 819-826.
81. Medzhitov R & Janeway C (2000) Innate immunity. N Engl J Med 343: 338-344.
82. Medzhitov R & Janeway CA (2002) Decoding the patterns of self and nonself by the innate immune system. Science 296: 298-300.
83. Mengelle C, Mansuy JM, Da Silva I, Davrinche C & Izopet J (2011) Comparison of 2 highly automated nucleic acid extraction systems for quantitation of human cytomegalovirus in whole blood. Diagn Microbiol Infect Dis 69: 161-166.
84. Mezger M, Bonin M, Kessler T, Gebhardt F, Einsele H & Loeffler J (2009) Toll-like receptor 3 has no critical role during early immune response of human monocyte-derived dendritic cells after infection with the human cytomegalovirus strain TB40E. Viral Immunol 22: 343-351.
85. Mockenhaupt FP, Hamann L, von Gaertner C, Bedu-Addo G, von Kleinsorgen C, Schumann RR & Bienzle U (2006) Common polymorphisms of toll-like receptors 4 and 9 are associated with the clinical manifestation of malaria during pregnancy. J Infect Dis 194: 184-188.
86. Mogensen TH (2009) Pathogen recognition and inflammatory signaling in innate immune defenses. Clin Microbiol Rev 22: 240-273.
87. Nahid MA, Yao B, Dominguez-Gutierrez PR, Kesavalu L, Satoh M & Chan EK (2012) Regulation of TLR2-mediated tolerance and cross-tolerance through IRAK4 modulation by miR-132 and miR-212. J Immunol 190: 1250-1263.
88. Nahum A, Dadi H, Bates A & Roifman CM (2012) The biological significance of TLR3 variant, L412F, in conferring susceptibility to cutaneous candidiasis, CMV and autoimmunity. Autoimmun Rev 11: 341-347.
89. Negishi M, Izumi Y, Aleemuzzaman S, Inaba N & Hayakawa S (2011) Lipopolysaccharide (LPS)-induced interferon (IFN)-gamma production by decidual mononuclear cells (DMNC) is interleukin (IL)-2 and IL-12 dependent. Am J Reprod Immunol 65: 20-27.
90. Netea MG, van de Veerdonk FL, van Deuren M & van der Meer JW (2011) Defects of pattern recognition: primary immunodeficiencies of the innate immune system. Curr Opin Pharmacol 11: 412-422.
91. Netea MG, Wijmenga C & O'Neill LA (2012) Genetic variation in Toll-like receptors and disease susceptibility. Nat Immunol 13: 535-542.
92. Nitsche JF, Jiang SW & Brost BC (2010) Toll-like receptor-2 and toll-like receptor-4 expression on maternal neutrophils during pregnancy. Am J Reprod Immunol 64: 427-434.
93. Oberg HH, Juricke M, Kabelitz D & Wesch D (2011) Regulation of T cell activation by TLR ligands. Eur J Cell Biol 90: 582-592.
94. O'Connell RM, Rao DS, Chaudhuri AA, Boldin MP, Taganov KD, Nicoll J, Paquette RL & Baltimore D (2008) Sustained expression of microRNA-155 in hematopoietic stem cells causes a myeloproliferative disorder. J Exp Med 205: 585-594.
95. O'Neill LA, Sheedy FJ & McCoy CE (2011) MicroRNAs: the fine-tuners of Toll-like receptor signalling. Nat Rev Immunol 11: 163-175.
96. Ozinsky A, Underhill DM, Fontenot JD, Hajjar AM, Smith KD, Wilson CB, Schroeder L & Aderem A (2000) The repertoire for pattern recognition of pathogens by the innate immune system is defined by cooperation between toll-like receptors. P Natl Acad Sci USA 97: 13766-13771.
97. Paradowska E, Przepiorkiewicz M, Nowakowska D, Studzinska M, Wilczynski J, Emery VC & Lesnikowski ZJ (2006) Detection of cytomegalovirus in human placental cells by polymerase chain reaction. APMIS 114: 764-771.
98. Paradowska E, Studzinska M, Nowakowska D, Wilczynski J, Rycel M, Suski P, Gaj Z, Kaczmarek B, Zbrog Z & Lesnikowski ZJ (2012) Distribution of UL144, US28 and UL55 genotypes in Polish newborns with congenital cytomegalovirus infections. Eur J Clin Microbiol Infect Dis 31: 1335-1345.
99. Patni S, Wynen LP, Seager AL, Morgan G, White JO & Thornton CA (2009) Expression and activity of Toll-like receptors 1-9 in the human term placenta and changes associated with labor at term. Biol Reprod 80: 243-248.
100. Pereyra S, Velazquez T, Bertoni B & Sapiro R (2012) Rapid multiplex high resolution melting method to analyze inflammatory related SNPs in preterm birth. BMC Res Notes 5: 69.
101. Perry MM, Moschos SA, Williams AE, Shepherd NJ, Larner-Svensson HM & Lindsay MA (2008) Rapid changes in microRNA-146a expression negatively regulate the IL-1beta-induced inflammatory response in human lung alveolar epithelial cells. J Immunol 180: 5689-5698.
102. Pizzato N, Garmy-Susini B, Le BP & Lenfant F (2004) Differential down-modulation of HLA-G and HLA-A2 or -A3 cell surface expression following human cytomegalovirus infection. J Reprod Immunol 62: 3-15.
103. Rautava S, Collado MC, Salminen S & Isolauri E (2012) Probiotics modulate host-microbe interaction in the placenta and fetal gut: a randomized, double-blind, placebo-controlled trial. Neonatology 102: 178-184.
104. Re F & Strominger JL (2001) Toll-like receptor 2 (TLR2) and TLR4 differentially activate human dendritic cells. J Biol Chem 276: 37692-37699.
105. Re F & Strominger JL (2004) IL-10 released by concomitant TLR2 stimulation blocks the induction of a subset of Th1 cytokines that are specifically induced by TLR4 or TLR3 in human dendritic cells. J Immunol 173: 7548-7555.
106. Renneson J, Dutta B, Goriely S, Danis B, Lecomte S, Laes JF, Tabi Z, Goldman M & Marchant A (2009) IL-12 and type I IFN response of neonatal myeloid DC to human CMV infection. Eur J Immunol 39: 2789-2799.
107. Revello MG & Gerna G (2010) Human cytomegalovirus tropism for endothelial/epithelial cells: scientific background and clinical implications. Rev Med Virol 20: 136-155.
108. Revello MG, Lilleri D, Zavattoni M, Furione M, Genini E, Comolli G & Gerna G (2006) Lymphoproliferative response in primary human cytomegalovirus (HCMV) infection is delayed in HCMV transmitter mothers. J Infect Dis 193: 269-276.
109. Revello MG, Fabbri E, Furione M et al. (2011) Role of prenatal diagnosis and counseling in the management of 735 pregnancies complicated by primary human cytomegalovirus infection: a 20-year experience. J Clin Virol 50: 303-307.
110. Rey G, Skowronek F, Alciaturi J, Alonso J, Bertoni B & Sapiro R (2008) Toll receptor 4 Asp299Gly polymorphism and its association with preterm birth and premature rupture of membranes in a South American population. Mol Hum Reprod 14: 555-559.
111. Ricci E, Malacrida S, Zanchetta M, Mosconi I, Montagna M, Giaquinto C & De Rossi A (2010) Toll-like receptor 9 polymorphisms influence mother-to-child transmission of human immunodeficiency virus type 1. J Transl Med 8: 49.
112. Riley JK & Nelson DM (2010) Toll-like receptors in pregnancy disorders and placental dysfunction. Clin Rev Allergy Immunol 39: 185-193.
113. Romero R, Chaiworapongsa T & Espinoza J (2003) Micronutrients and intrauterine infection, preterm birth and the fetal inflammatory response syndrome. J Nutr 133(5 suppl 2): 1668S-1673S.
114. Rose JA, Rabenold JJ, Parast MM, Milstone DS, Abrahams VM & Riley JK (2011) Peptidoglycan induces necrosis and regulates cytokine production in murine trophoblast stem cells. Am J Reprod Immunol 66: 209-222.
115. Rossini G, Cerboni C, Santoni A, Landini MP, Landolfo S, Gatti D, Gribaudo G & Varani S (2012) Interplay between human cytomegalovirus and intrinsic/innate host responses: a complex bidirectional relationship. Mediators Inflamm 2012: 607276.
116. Roszak A, Lianeri M, Sowinska A & Jagodzinski PP (2012) Involvement of toll-like receptor 9 polymorphism in cervical cancer development. Mol Biol Rep 39: 8425-8430.
117. Ryckman KK, Williams SM, Krohn MA & Simhan HN (2009) Genetic association of Toll-like receptor 4 with cervical cytokine concentrations during pregnancy. Genes Immun 10: 636-640.
118. Ryckman KK, Williams SM, Krohn MA & Simhan HN (2011) Interaction between interleukin-1 receptor 2 and Toll-like receptor 4, and cervical cytokines. J Reprod Immunol 90: 220-226.
119. Sadeghi K, Berger A, Langgartner M, Prusa AR, Hayde M, Herkner K, Pollak A, Spittler A & Forster-Waldl E (2007) Immaturity of infection control in preterm and term newborns is associated with impaired toll-like receptor signaling. J Infect Dis 195: 296-302.
120. Sado T, Naruse K, Noguchi T, Haruta S, Yoshida S, Tanase Y, Kitanaka T, Oi H & Kobayashi H (2011) Inflammatory pattern recognition receptors and their ligands: factors contributing to the pathogenesis of preeclampsia. Inflamm Res 60: 509-520.
121. Sawian CE, Lourembam SD, Banerjee A & Baruah S (2013) Polymorphisms and expression of TLR4 and 9 in malaria in two ethnic groups of Assam, northeast India. Innate Immun 19: 174-183.
122. Schatz F, Kayisli UA, Vatandaslar E, Ocak N, Guller S, Abrahams VM, Krikun G & Lockwood CJ (2012) Toll-like receptor 4 expression in decidual cells and interstitial trophoblasts across human pregnancy. Am J Reprod Immunol 68: 146-153.
123. Schilling D, Thomas K, Nixdorff K, Vogel SN & Fenton MJ (2002) Toll-like receptor 4 and Toll-IL-1 receptor domain-containing adapter protein (TIRAP)/myeloid differentiation protein 88 adapter-like (Mal) contribute to maximal IL-6 expression in macrophages. J Immunol 169: 5874-5880.
124. Sia IG, Wilson JA, Espy MJ, Paya CV & Smith TF (2000) Evaluation of the COBAS AMPLICOR CMV MONITOR test for detection of viral DNA in specimens taken from patients after liver transplantation. J Clin Microbiol 38: 600-606.
125. Simhan HN, MacPherson T, Caritis SN & Krohn MA (2008) Maternal and fetal Toll-like receptor 4 genotype and chorionic plate inflammatory lesions. Am J Obstet Gynecol 199: 400-404.
126. + T cells despite late downregulation of MHC class II molecules. J Gen Virol 87: 1853-1862.
127. Stewart CR, Stuart LM, Wilkinson K et al. (2010) CD36 ligands promote sterile inflammation through assembly of a Toll-like receptor 4 and 6 heterodimer. Nat Immunol 11: 155-161.
128. Syggelou A, Iacovidou N, Kloudas S, Christoni Z & Papaevangelou V (2010) Congenital cytomegalovirus infection. Ann NY Acad Sci 1205: 144-147.
129. Szomolanyi-Tsuda E, Liang X, Welsh RM et al. (2006) Role for TLR2 in NK cell-mediated control of murine cytomegalovirus in vivo. J Virol 80: 4286-4291.
130. Tabeta K, Georgel P, Janssen E et al. (2004) Toll-like receptors 9 and 3 as essential components of innate immune defense against mouse cytomegalovirus infection. P Natl Acad Sci USA 101: 3516-3521.
131. Takeda K, Kaisho T & Akira S (2003) Toll-like receptors. Annu Rev Immunol 21: 335-376.
132. Texereau J, Chiche JD, Taylor W, Choukroun G, Comba B & Mira JP (2005) The importance of Toll-like receptor 2 polymorphisms in severe infections. Clin Infect Dis 41(suppl 7): S408-S415.
133. Thaxton JE, Romero R & Sharma S (2009) TLR9 activation coupled to IL-10 deficiency induces adverse pregnancy outcomes. J Immunol 183: 1144-1154.
134. Tili E, Michaille JJ, Cimino A et al. (2007) Modulation of miR-155 and miR-125b levels following lipopolysaccharide/TNF-alpha stimulation and their possible roles in regulating the response to endotoxin shock. J Immunol 179: 5082-5089.
135. Traub S, Demaria O, Chasson L et al. (2012) Sex bias in susceptibility to MCMV infection: implication of TLR9. PLoS ONE 7: e45171.
136. van Maren WW, Jacobs JF, de Vries IJ, Nierkens S & Adema GJ (2008) Toll-like receptor signalling on Tregs: to suppress or not to suppress? Immunology 124: 445-452.
137. Varani S, Cederarv M, Feld S, Tammik C, Frascaroli G, Landini MP & Soderberg-Naucler C (2007) Human cytomegalovirus differentially controls B cell and T cell responses through effects on plasmacytoid dendritic cells. J Immunol 179: 7767-7776.
138. Varner MW & Esplin MS (2005) Current understanding of genetic factors in preterm birth. Br J Obstet Gynaecol 112(suppl 1): 28-31.
139. Velez DR, Wejse C, Stryjewski ME et al. (2010) Variants in toll-like receptors 2 and 9 influence susceptibility to pulmonary tuberculosis in Caucasians, African-Americans, and West Africans. Hum Genet 127: 65-73.
140. Vrachnis N, Vitoratos N, Iliodromiti Z, Sifakis S, Deligeoroglou E & Creatsas G (2010) Intrauterine inflammation and preterm delivery. Ann NY Acad Sci 1205: 118-122.
141. Vrachnis N, Karavolos S, Iliodromiti Z, Sifakis S, Siristatidis C, Mastorakos G & Creatsas G (2012) Impact of mediators present in amniotic fluid on preterm labour. In Vivo 26: 799-812.
142. Wang JP, Zhang Y, Wei X, Li J, Nan XP, Yu HT, Li Y, Wang PZ & Bai XF (2010) Circulating Toll-like receptor (TLR) 2, TLR4, and regulatory T cells in patients with chronic hepatitis C. APMIS 118: 261-270.
143. Wang CH, Eng HL, Lin KH, Chang CH, Hsieh CA, Lin YL & Lin TM (2011) TLR7 and TLR8 gene variations and susceptibility to hepatitis C virus infection. PLoS ONE 6: e26235.
144. Wilkins C & Gale M (2010) Recognition of viruses by cytoplasmic sensors. Curr Opin Immunol 22: 41-47.
145. Wujcicka W, Wilczyński J & Nowakowska D (2013) SNPs in toll-like receptor (TLR) genes as new genetic alterations associated with congenital toxoplasmosis? Eur J Clin Microbiol Infect Dis 32: 503-511.
146. Xie F, Hu Y, Speert DP, Turvey SE, Peng G, Money DM, Magee LA & von Dadelszen P (2010) Toll-like receptor gene polymorphisms and preeclampsia risk: a case-control study and data synthesis. Hypertens Pregnancy 29: 390-398.
147. Yew KH & Harrison CJ (2011) Blockade of Lyn kinase upregulates both canonical and non-canonical TLR-3 pathways in THP-1 monocytes exposed to human cytomegalovirus. Acta Virol 55: 243-253.
148. Yew KH, Carsten B & Harrison C (2010) Scavenger receptor A1 is required for sensing HCMV by endosomal TLR-3/-9 in monocytic THP-1 cells. Mol Immunol 47: 883-893.
149. Yew KH, Carpenter C, Duncan RS & Harrison CJ (2012) Human cytomegalovirus induces TLR4 signaling components in monocytes altering TIRAP, TRAM and downstream interferon-beta and TNF-alpha expression. PLoS ONE 7: e44500.
150. Yinon Y, Farine D & Yudin MH (2010) Screening, diagnosis, and management of cytomegalovirus infection in pregnancy. Obstet Gynecol Surv 65: 736-743.
151. Zariffard MR, Novak RM, Lurain N, Sha BE, Graham P & Spear GT (2005) Induction of tumor necrosis factor-alpha secretion and toll-like receptor 2 and 4 mRNA expression by genital mucosal fluids from women with bacterial vaginosis. J Infect Dis 191: 1913-1921.